Literature DB >> 30836273

Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?

Melina da Silva Bernardes1, Carmen Lucia Antão Paiva2, Eduardo Ribeiro Paradela3, Marcos Papais Alvarenga4, Fernanda Ferreira Pereira3, Claudia Cristina Vasconcelos4, Regina Maria Papais Alvarenga4.   

Abstract

BACKGROUND: The HLA-DR15 extended haplotype HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 comprises the strongest genetic risk factor for multiple sclerosis (MS). The aim of this work was to investigate whether HLA-DR15 alleles were significantly associated with the susceptibility to MS familial forms (MSf) in an admixed Brazilian population.
METHODS: Association analyses between DR15 and the clinical and demographic variables were made.
RESULTS: We have genotyped 25 familial cases. The DR15 was detected in 11/25 (44%) of them and in none of controls (P < .00001). DR15 was significantly associated to a foreign ancestor background (P = .029) and later age of onset (P = .018).
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brazilians; Familial; HLA-DR15; HLA-DRB1; Multiple sclerosis; Susceptibility

Mesh:

Substances:

Year:  2019        PMID: 30836273     DOI: 10.1016/j.jneuroim.2019.02.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.

Authors:  Andrina Rutsch; Johan B Kantsjö; Francesca Ronchi
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

2.  Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.

Authors:  Zahra Salehi; Amir Almasi-Hashiani; Mohammad Ali Sahraian; Fereshteh Ashtari; Seyed Mohammad Baghbanian; Nazanin Razazian; Abdorreza Naser Moghadasi; Asghar Bayati; Amir Reza Azimi; Nahid Beladimoghadam; Mohammad Hossein Harirchian; Maryam Poursadeghfard; Samira Navardi; Reza Shirkoohi; Hora Heidari; Mehran Ghaffari; Sharareh Eskandarieh
Journal:  BMC Neurol       Date:  2022-03-05       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.